Works by Nagashima, Seiji


Results: 31
    1

    Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating Factor.

    Published in:
    Journal of Clinical Medicine, 2021, v. 10, n. 18, p. 4221, doi. 10.3390/jcm10184221
    By:
    • Dotsu, Yosuke;
    • Yamaguchi, Hiroyuki;
    • Fukuda, Minoru;
    • Suyama, Takayuki;
    • Honda, Noritaka;
    • Umeyama, Yasuhiro;
    • Taniguchi, Hirokazu;
    • Gyotoku, Hiroshi;
    • Takemoto, Shinnosuke;
    • Tagawa, Ryuta;
    • Ogata, Ryosuke;
    • Tomono, Hiromi;
    • Shimada, Midori;
    • Senju, Hiroaki;
    • Nakatomi, Katsumi;
    • Nagashima, Seiji;
    • Soda, Hiroshi;
    • Ikeda, Hiroaki;
    • Ashizawa, Kazuto;
    • Mukae, Hiroshi
    Publication type:
    Article
    2

    Phase II Trial on Osimertinib as a First-Line Treatment for EGFR Mutation-Positive Advanced NSCLC in Elderly Patients: The SPIRAL-0 Study.

    Published in:
    Oncologist, 2022, v. 27, n. 11, p. 903, doi. 10.1093/oncolo/oyac193
    By:
    • Chihara, Yusuke;
    • Takeda, Takayuki;
    • Goto, Yasuhiro;
    • Nakamura, Yoichi;
    • Tsuchiya-Kawano, Yuko;
    • Nakao, Akira;
    • Onoi, Keisuke;
    • Hibino, Makoto;
    • Fukuda, Minoru;
    • Honda, Ryoichi;
    • Yamada, Takahiro;
    • Taniguchi, Ryusuke;
    • Sakamoto, Sinjiro;
    • Date, Koji;
    • Nagashima, Seiji;
    • Tanzawa, Shigeru;
    • Minato, Koichi;
    • Nakatani, Koichi;
    • Izumi, Miiru;
    • Shimose, Takayuki
    Publication type:
    Article
    3
    4
    5

    A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 3, p. 497, doi. 10.1007/s00280-014-2527-4
    By:
    • Ikeda, Takaya;
    • Fukuda, Minoru;
    • Nakamura, Yoichi;
    • Kinoshita, Akitoshi;
    • Senju, Hiroaki;
    • Nakano, Hirofumi;
    • Kitazaki, Takeshi;
    • Ogawara, Daiki;
    • Taniguchi, Hirokazu;
    • Motoshima, Kohei;
    • Yamaguchi, Hiroyuki;
    • Nakatomi, Katsumi;
    • Shimada, Midori;
    • Nagashima, Seiji;
    • Tsukamoto, Kazuhiro;
    • Kohno, Shigeru
    Publication type:
    Article
    6
    7

    Phase II trial of erlotinib in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations: additive analysis of pharmacokinetics.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1299, doi. 10.1007/s00280-013-2307-6
    By:
    • Motoshima, Kohei;
    • Nakamura, Yoichi;
    • Sano, Kazumi;
    • Ikegami, Yoji;
    • Ikeda, Takaya;
    • Mizoguchi, Kosuke;
    • Takemoto, Shinnosuke;
    • Fukuda, Minoru;
    • Nagashima, Seiji;
    • Iida, Tetsuya;
    • Tsukamoto, Kazuhiro;
    • Kohno, Shigeru
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II-IIIA non-small cell lung cancer: study protocol for a randomized controlled trial.

    Published in:
    2017
    By:
    • Hideo Saka;
    • Chiyoe Kitagawa;
    • Yukito Ichinose;
    • Mitsuhiro Takenoyama;
    • Hidenori Ibata;
    • Tatsuo Kato;
    • Koji Takami;
    • Motohiro Yamashita;
    • Tadashi Maeda;
    • Sadanori Takeo;
    • Hitoshi Ueda;
    • Kan Okabayashi;
    • Seiji Nagashima;
    • Tadayuki Oka;
    • Hidenori Kouso;
    • Seiichi Fukuyama;
    • Kentaro Yoshimoto;
    • Mototsugu Shimokawa;
    • Saito, Akiko M.;
    • Suminobu Ito
    Publication type:
    journal article
    18

    The definition of healthcare-associated pneumonia (HCAP) is insufficient for the medical environment in Japan: a comparison of HCAP and nursing and healthcare-associated pneumonia (NHCAP).

    Published in:
    Journal of Infection & Chemotherapy (Springer Science & Business Media B.V.), 2013, v. 19, n. 1, p. 70, doi. 10.1007/s10156-012-0454-z
    By:
    • Kaku, Norihito;
    • Yanagihara, Katsunori;
    • Morinaga, Yoshitomo;
    • Izumikawa, Koichi;
    • Nagashima, Seiji;
    • Kakeya, Hiroshi;
    • Yamamoto, Yoshihiro;
    • Fukuda, Minoru;
    • Takatani, Hiroshi;
    • Fukuda, Masaaki;
    • Hashiguchi, Kohji;
    • Kohno, Shigeru
    Publication type:
    Article
    19

    Detection of Legionella pneumophila serogroup 1 in blood cultures from a patient treated with tumor necrosis factor-alpha inhibitor.

    Published in:
    Journal of Infection & Chemotherapy (Springer Science & Business Media B.V.), 2013, v. 19, n. 1, p. 166, doi. 10.1007/s10156-012-0459-7
    By:
    • Kaku, Norihito;
    • Yanagihara, Katsunori;
    • Morinaga, Yoshitomo;
    • Sato, Tsuyoshi;
    • Nakashima, Munetoshi;
    • Sakai, Takahiro;
    • Tominaga, Hiroo;
    • Wakigawa, Fumiko;
    • Nagashima, Seiji;
    • Fukuda, Minoru;
    • Hashiguchi, Kohji;
    • Kohno, Shigeru
    Publication type:
    Article
    20
    21
    22

    Phase II study of IRInotecan treatment after COmbined chemo‐immunotherapy for extensive‐stage small cell lung cancer: Protocol of IRICO study.

    Published in:
    Thoracic Cancer, 2023, v. 14, n. 28, p. 2890, doi. 10.1111/1759-7714.15097
    By:
    • Tomono, Hiromi;
    • Taniguchi, Hirokazu;
    • Fukuda, Minoru;
    • Ikeda, Takaya;
    • Nagashima, Seiji;
    • Akagi, Kazumasa;
    • Ono, Sawana;
    • Umeyama, Yasuhiro;
    • Shimada, Midori;
    • Gyotoku, Hiroshi;
    • Takemoto, Shinnosuke;
    • Hisamatsu, Yasushi;
    • Morinaga, Ryotaro;
    • Tagawa, Ryuta;
    • Ogata, Ryosuke;
    • Dotsu, Yosuke;
    • Senju, Hiroaki;
    • Soda, Hiroshi;
    • Nakatomi, Katsumi;
    • Hayashi, Fumiko
    Publication type:
    Article
    23

    Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited‐disease small cell lung cancer: protocol of ACIST study.

    Published in:
    Thoracic Cancer, 2022, v. 13, n. 16, p. 2404, doi. 10.1111/1759-7714.14555
    By:
    • Akagi, Kazumasa;
    • Taniguchi, Hirokazu;
    • Fukuda, Minoru;
    • Yamazaki, Takuya;
    • Ono, Sawana;
    • Tomono, Hiromi;
    • Suyama, Takayuki;
    • Shimada, Midori;
    • Gyotoku, Hiroshi;
    • Takemoto, Shinnosuke;
    • Yamaguchi, Hiroyuki;
    • Dotsu, Yosuke;
    • Senju, Hiroaki;
    • Soda, Hiroshi;
    • Mizowaki, Takashi;
    • Monzen, Yoshio;
    • Ikeda, Takaya;
    • Nagashima, Seiji;
    • Tasaki, Yutaro;
    • Nakamura, Daisuke
    Publication type:
    Article
    24

    Phase II study of ramucirumab and docetaxel for previously treated non‐small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study.

    Published in:
    Thoracic Cancer, 2020, v. 11, n. 2, p. 389, doi. 10.1111/1759-7714.13279
    By:
    • Takemoto, Shinnosuke;
    • Fukuda, Minoru;
    • Yamaguchi, Hiroyuki;
    • Ikeda, Takaya;
    • Akagi, Kazumasa;
    • Tomono, Hiromi;
    • Umeyama, Yasuhiro;
    • Dotsu, Yosuke;
    • Taniguchi, Hirokazu;
    • Gyotoku, Hiroshi;
    • Senju, Hiroaki;
    • Kitazaki, Takeshi;
    • Nakatomi, Katsumi;
    • Nagashima, Seiji;
    • Fukuda, Masaaki;
    • Kinoshita, Akitoshi;
    • Soda, Hiroshi;
    • Mukae, Hiroshi
    Publication type:
    Article
    25

    Phase II study of nedaplatin and amrubicin as first‐line treatment for advanced squamous cell lung cancer.

    Published in:
    Thoracic Cancer, 2019, v. 10, n. 9, p. 1764, doi. 10.1111/1759-7714.13134
    By:
    • Taniguchi, Hirokazu;
    • Yamaguchi, Hiroyuki;
    • Dotsu, Yosuke;
    • Shimada, Midori;
    • Gyotoku, Hiroshi;
    • Senju, Hiroaki;
    • Takemoto, Shinnosuke;
    • Kitazaki, Takeshi;
    • Fukuda, Masaaki;
    • Ogawara, Daiki;
    • Soda, Hiroshi;
    • Nakatomi, Katsumi;
    • Sugasaki, Nanae;
    • Kinoshita, Akitoshi;
    • Nagashima, Seiji;
    • Ikeda, Takaya;
    • Nakamura, Yoichi;
    • Sakamoto, Noriho;
    • Obase, Yasushi;
    • Fukuda, Minoru
    Publication type:
    Article
    26

    Phase II trial of a non‐platinum triplet for patients with advanced non‐small cell lung carcinoma (NSCLC) overexpressing ERCC1 messenger RNA.

    Published in:
    Thoracic Cancer, 2019, v. 10, n. 3, p. 452, doi. 10.1111/1759-7714.12958
    By:
    • Takemoto, Shinnosuke;
    • Nakamura, Yoichi;
    • Gyoutoku, Hiroshi;
    • Senju, Hiroaki;
    • Ogawara, Daiki;
    • Ikeda, Takaya;
    • Yamaguchi, Hiroyuki;
    • Kitazaki, Takeshi;
    • Nakano, Hirofumi;
    • Nakatomi, Katsumi;
    • Tomari, Shinya;
    • Sato, Shuntaro;
    • Nagashima, Seiji;
    • Fukuda, Minoru;
    • Mukae, Hiroshi
    Publication type:
    Article
    27

    Phase I study of irinotecan for previously treated lung cancer patients with the UGT1A1 * 28 or * 6 polymorphism: Results of the Lung Oncology Group in Kyushu ( LOGIK1004 A).

    Published in:
    Thoracic Cancer, 2017, v. 8, n. 1, p. 40, doi. 10.1111/1759-7714.12407
    By:
    • Fukuda, Minoru;
    • Shimada, Midori;
    • Kitazaki, Takeshi;
    • Nagashima, Seiji;
    • Hashiguchi, Kohji;
    • Ebi, Noriyuki;
    • Takayama, Koichi;
    • Nakanishi, Yoichi;
    • Semba, Hiroshi;
    • Harada, Taishi;
    • Seto, Takashi;
    • Okamoto, Isamu;
    • Ichinose, Yukito;
    • Sugio, Kenji
    Publication type:
    Article
    28
    29
    30
    31